Skip to main content

CORRECTION article

Front. Microbiol., 06 November 2023
Sec. Infectious Agents and Disease
Volume 14 - 2023 | https://doi.org/10.3389/fmicb.2023.1322004
This article is part of the Research Topic New Insights in Prosthetic Joint Infections View all 8 articles

Corrigendum: Difference of gut microbiota between patients with negative and positive HBeAg in chronic hepatitis B and the effect of tenofovir alafenamide on intestinal flora

This article is a correction to:

  1. Difference of gut microbiota between patients with negative and positive HBeAg in chronic hepatitis B and the effect of tenofovir alafenamide on intestinal flora

    1. Read original article
\r\nJianfei Long&#x;Jianfei Long1†Jingru Gong&#x;Jingru Gong2†Han ZhuHan Zhu2Xiaolin LiuXiaolin Liu2Ling LiLing Li3Bicui ChenBicui Chen1Hongyan RenHongyan Ren4Chao LiuChao Liu4Huiping Lu Huiping Lu2*Jiming Zhang,, Jiming Zhang5,6,7*Bin Wang, &#x;Bin Wang1,3*‡
  • 1Department of Pharmacy, Huashan Hospital, Fudan University, Shanghai, China
  • 2Department of Pharmacy, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, Shanghai, China
  • 3Department of Pharmacy, Jing'an District Central Hospital, Fudan University, Shanghai, China
  • 4Shanghai Mobio Biomedical Technology Co., Ltd., Shanghai, China
  • 5Department of Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, National Medical Center for Infectious Diseases, Huashan Hospital, Fudan University, Shanghai, China
  • 6Shanghai Institute of Infectious Diseases and Biosecurity, Key Laboratory of Medical Molecular Virology (MOE/MOH), Shanghai Medical College, Fudan University, Shanghai, China
  • 7Department of Infectious Diseases, Jing'An Branch of Huashan Hospital, Fudan University, Shanghai, China

A corrigendum on
Difference of gut microbiota between patients with negative and positive HBeAg in chronic hepatitis B and the effect of tenofovir alafenamide on intestinal flora

by Long, J., Gong, J., Zhu, H., Liu, X., Li, L., Chen, B., Ren, H., Liu, C., Lu, H., Zhang, J., and Wang, B. (2023). Front. Microbiol. 14:1232180. doi: 10.3389/fmicb.2023.1232180

In the published article, there was an error in Figure 4. The horizontal axis previously stated, “White ball ratio” which should be corrected as follows: “Albumin-globulin ratio”. The corrected Figure appears below.

FIGURE 4
www.frontiersin.org

Figure 4. Effect size (adoniss R2) of metadata on microbiota was calculated using the adonis2 function in the vegan package with 999 permutations.

In the published article, there was an error in the Results subsection 5.2, page 3. “Differences in gut microbiota between Phase 1 and Phase 2 in No-NAs group CHB patients”.

“The results of species accumulation curves and the Venn plot (Figure 1A) revealed that 31 and 118 ASVs were independently present in Phase 1 and Phase 2 subgroups, respectively.”

The corrected sentence appears below:

“The results of species accumulation curves and the Venn plot (Figure 1A) revealed that 31 and 110 ASVs were independently present in Phase 1 and Phase 2 subgroups, respectively.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: hepatitis B virus, HBeAg, HBsAg, tenofovir alafenamide, gut microbiota

Citation: Long J, Gong J, Zhu H, Liu X, Li L, Chen B, Ren H, Liu C, Lu H, Zhang J and Wang B (2023) Corrigendum: Difference of gut microbiota between patients with negative and positive HBeAg in chronic hepatitis B and the effect of tenofovir alafenamide on intestinal flora. Front. Microbiol. 14:1322004. doi: 10.3389/fmicb.2023.1322004

Received: 15 October 2023; Accepted: 25 October 2023;
Published: 06 November 2023.

Edited and reviewed by: George Grant, University of Aberdeen, United Kingdom

Copyright © 2023 Long, Gong, Zhu, Liu, Li, Chen, Ren, Liu, Lu, Zhang and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Huiping Lu, bGhwMzEwJiN4MDAwNDA7MTI2LmNvbQ==; Jiming Zhang, am16aGFuZyYjeDAwMDQwO2Z1ZGFuLmVkdS5jbg==; Bin Wang, d2FuZ2JpbiYjeDAwMDQwO2h1YXNoYW4ub3JnLmNu

†These authors have contributed equally to this work

‡ORCID: Bin Wang orcid.org/0000-0003-1067-7683

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.